NEW YORK, June 28 - Entigen has hired Denise Gilbert, a former executive at Incyte and Affymax, as the company's new CEO, Entigen announced Thursday.

As CEO, Gilbert will work on marketing Entigen's technology platform and expanding the business beyond its traditional focus on bioinformatics. The company has yet to disclose specifics on its new direction.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.